Burt A. Adelman
EVP, Development, Biogen.
Companies
- Verve Therapeutics, Inc.Board member Jun 16, 2021 to now1
- Catabasis PharmaceuticalsBoard member Apr 7, 2016 to Jun 12, 20202
- BiogenEVP, Development Jan 5, 2006 to Feb 14, 20083
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Verve Therapeutics, Inc.0 shares4Jul 25, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Jul 25, 2025U 428,326 shares of Verve Therapeutics, Inc.4
- Sep 18, 2023Gift 37,168 shares of Verve Therapeutics, Inc.5
- Sep 18, 2023Gift 37,168 shares of Verve Therapeutics, Inc.5
- Aug 11, 2023Gift 266,258 shares of Verve Therapeutics, Inc.5
- Aug 11, 2023Gift 266,258 shares of Verve Therapeutics, Inc.5
- Nov 7, 2022Gift 106,200 shares of Verve Therapeutics, Inc.5
- Nov 7, 2022Gift 106,200 shares of Verve Therapeutics, Inc.5
- May 12, 2022Bought 10,000 shares at $12.15 of Verve Therapeutics, Inc.6
- Mar 15, 2022Bought 4,000 shares at $21.38 of Verve Therapeutics, Inc.7
- Dec 2, 2021Bought 4,700 shares at $31.34 of Verve Therapeutics, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARBiogen, EVP, Development
- 4
- 5SEC EDGARForm 5 filed Feb 9, 2024
- 6SEC EDGARForm 4 filed May 13, 2022
- 7SEC EDGARForm 4 filed Mar 17, 2022
- 8SEC EDGARForm 4 filed Dec 6, 2021